An animal study showed increased MMP-9, the receptor for advanced glycation end products, and vascular endothelial growth factor in diabetic mice, which were associated with increased blood–brain barrier leakage (17), which can explain why hemorrhage transformation was more commonly observed in acute stroke patients with diabetes mellitus who received reperfusion therapy than in patients without diabetes mellitus. This evidence concerns the gene MMP9 and diabetes mellitus.